RECURRENT WHO GRADE 2 GLIOMA
Clinical trials for RECURRENT WHO GRADE 2 GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT WHO GRADE 2 GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT WHO GRADE 2 GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for recurrent brain cancer? drug duo enters early testing
Disease control Recruiting nowThis early-stage trial tests a combination of two drugs, triapine and temozolomide, in about 30 adults whose glioblastoma (a type of brain cancer) has come back. The main goal is to find the safest dose and understand side effects. The drugs work by damaging cancer cells' DNA to …
Matched conditions: RECURRENT WHO GRADE 2 GLIOMA
Phase: PHASE1 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 26, 2026 03:33 UTC
-
New hope for brain cancer: targeted pill shrinks tumors in early trial
Disease control Recruiting nowThis study tests a pill called erdafitinib in 30 adults with a specific type of brain tumor (glioma) that has returned or is growing. The tumor must have a certain gene change (FGFR-TACC fusion). The drug blocks a faulty protein that helps tumors grow, aiming to slow or shrink th…
Matched conditions: RECURRENT WHO GRADE 2 GLIOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:56 UTC